AAAAAA

   
Results: 1-21 |
Results: 21
Psychoneuroendocrinology of mood disorders
Authors: Dinan, TG
Citation: Tg. Dinan, Psychoneuroendocrinology of mood disorders, CUR OPIN P, 14(1), 2001, pp. 51-55
Glucocorticoids and cognitive function: from physiology to pathophysiology
Authors: Jameison, K Dinan, TG
Citation: K. Jameison et Tg. Dinan, Glucocorticoids and cognitive function: from physiology to pathophysiology, HUM PSYCHOP, 16(4), 2001, pp. 293-302
Novel approaches to the treatment of depression by modulating the hypothalamic-pituitary-adrenal axis
Authors: Dinan, TG
Citation: Tg. Dinan, Novel approaches to the treatment of depression by modulating the hypothalamic-pituitary-adrenal axis, HUM PSYCHOP, 16(1), 2001, pp. 89-93
Impact of cortisol on buspirone stimulated prolactin release: a double-blind placebo-controlled study
Authors: Dinan, TG Scott, LV Thakore, J Naesdal, J Keeling, PWN
Citation: Tg. Dinan et al., Impact of cortisol on buspirone stimulated prolactin release: a double-blind placebo-controlled study, PSYCHONEURO, 26(7), 2001, pp. 751-756
A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia - are central serotoninergic responses enhanced?
Authors: Dinan, TG Mahmud, N Rathore, O Thakore, J Scott, LV Carr, E Naesdal, J O'Morain, CA Keeling, PWN
Citation: Tg. Dinan et al., A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia - are central serotoninergic responses enhanced?, ALIM PHARM, 15(10), 2001, pp. 1613-1618
Efficacy and safety of weekly treatment with enteric-coated fluoxetine in patients with major depressive disorder
Authors: Dinan, TG
Citation: Tg. Dinan, Efficacy and safety of weekly treatment with enteric-coated fluoxetine in patients with major depressive disorder, J CLIN PSY, 62, 2001, pp. 48-52
Selective serotonin reuptake inhibitors and violence: a review of the available evidence
Authors: Walsh, MT Dinan, TG
Citation: Mt. Walsh et Tg. Dinan, Selective serotonin reuptake inhibitors and violence: a review of the available evidence, ACT PSYC SC, 104(2), 2001, pp. 84-91
The hypothalamic-pituitary-adrenal axis and antidepressant action
Authors: Dinan, TG
Citation: Tg. Dinan, The hypothalamic-pituitary-adrenal axis and antidepressant action, MIL DRUG TH, 2001, pp. 83-94
Prednisone augmentation in treatment-resistant depression with fatigue andhypocortisolaemia: A case series
Authors: Bouwer, C Claassen, J Dinan, TG Nemeroff, CB
Citation: C. Bouwer et al., Prednisone augmentation in treatment-resistant depression with fatigue andhypocortisolaemia: A case series, DEPRESS ANX, 12(1), 2000, pp. 44-50
Antidepressants and violence: Cause for concern or media hype?
Authors: Dinan, TG
Citation: Tg. Dinan, Antidepressants and violence: Cause for concern or media hype?, HUM PSYCHOP, 15(6), 2000, pp. III-IV
Hypothalamic-pituitary-adrenal axis early-feedback responses are preservedin melancholic depression: A study of sertraline treatment
Authors: Cooney, JM Dinan, TG
Citation: Jm. Cooney et Tg. Dinan, Hypothalamic-pituitary-adrenal axis early-feedback responses are preservedin melancholic depression: A study of sertraline treatment, HUM PSYCHOP, 15(5), 2000, pp. 351-356
The physical consequences of depressive illness - Include coronary artery disease and reduced bone mineral density
Authors: Dinan, TG
Citation: Tg. Dinan, The physical consequences of depressive illness - Include coronary artery disease and reduced bone mineral density, BR MED J, 318(7187), 1999, pp. 826-826
A preliminary study of dexamethasone treatment on pituitary-adrenal responsivity in major depression
Authors: Scott, LV Thakore, J Burnett, F Dinan, TG
Citation: Lv. Scott et al., A preliminary study of dexamethasone treatment on pituitary-adrenal responsivity in major depression, HUM PSYCHOP, 14(8), 1999, pp. 587-591
Diurnal variation of nicotine-induced ACTH and cortisol secretion in non-smoking healthy male volunteers
Authors: Thakore, JH Berti, C Dinan, TG
Citation: Jh. Thakore et al., Diurnal variation of nicotine-induced ACTH and cortisol secretion in non-smoking healthy male volunteers, HUM PSYCHOP, 14(3), 1999, pp. 179-183
Schizophrenia: illness, stigma and misconceptions
Authors: Dinan, TG
Citation: Tg. Dinan, Schizophrenia: illness, stigma and misconceptions, IRIS J PS M, 16(1), 1999, pp. 3-4
Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study
Authors: Scott, LV Teh, J Reznek, R Martin, A Sohaib, A Dinan, TG
Citation: Lv. Scott et al., Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study, PSYCHONEURO, 24(7), 1999, pp. 759-768
ACTH and cortisol release following intravenous desmopressin: a dose-response study
Authors: Scott, LV Medbak, S Dinan, TG
Citation: Lv. Scott et al., ACTH and cortisol release following intravenous desmopressin: a dose-response study, CLIN ENDOCR, 51(5), 1999, pp. 653-658
Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health
Authors: Scott, LV Salahuddin, F Cooney, J Svec, F Dinan, TG
Citation: Lv. Scott et al., Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health, J AFFECT D, 54(1-2), 1999, pp. 129-137
The effect of naloxone on adrenocorticotropin and cortisol release: evidence for a reduced response in depression
Authors: Burnett, FE Scott, LV Weaver, MG Medbak, SH Dinan, TG
Citation: Fe. Burnett et al., The effect of naloxone on adrenocorticotropin and cortisol release: evidence for a reduced response in depression, J AFFECT D, 53(3), 1999, pp. 263-268
Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: Evidence of enhanced vasopressinergic responsivity
Authors: Dinan, TG Lavelle, E Scott, LV Newell-Price, J Medbak, S Grossman, AB
Citation: Tg. Dinan et al., Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: Evidence of enhanced vasopressinergic responsivity, J CLIN END, 84(6), 1999, pp. 2238-2240
Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers
Authors: Scott, LV Medbak, S Dinan, TG
Citation: Lv. Scott et al., Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers, BIOL PSYCHI, 45(11), 1999, pp. 1447-1454
Risultati: 1-21 |